BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35791975)

  • 1. [Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC].
    Forcade E; Bacquet S; Ballot C; Capin L; Garnier F; Giraud C; Guérout-Vérité MA; Letellier C; Magnani A; Mamez AC; Nasone J; Sinayoko M; Baudoux E; Mialou V; Yakoub-Agha I; Calmels B
    Bull Cancer; 2023 Feb; 110(2S):S39-S47. PubMed ID: 35791975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral feeding of patient hospitalized for allogeneic stem cells transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Dendoncker C; Brouillat C; Daufrene L; Deledicque V; El Cheikh J; Gibault-Joffe C; Guilbert Y; Guidi V; Hadrot L; Haran I; Kermeur G; Kernoa K; L'Hostette A; Mercier L; Mouneydier K; Servais S; Withofs S; Yakoub-Agha I; Farrugia C
    Bull Cancer; 2020 Jan; 107(1S):S36-S43. PubMed ID: 31615648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
    Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
    Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
    Purtill D; Antonenas V; Chiappini P; Tong D; O'Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai L; Greenwood M; Gottlieb DJ; Hamad N
    Blood Adv; 2020 Sep; 4(17):4147-4150. PubMed ID: 32886750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Bay JO; Beguin Y; Carpentier A; Dard C; Guillaume T; Labussiere-Wallet H; Lacassagne MN; Sauze S; Yakoub-Agha I; Chalandon Y
    Bull Cancer; 2021 Dec; 108(12S):S20-S25. PubMed ID: 34215432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
    Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
    Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
    Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
    Front Immunol; 2022; 13():937900. PubMed ID: 36203566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    De Vos J; Baudoux E; Bay JO; Calmels B; Cras A; El Cheikh J; Guerout-Verite MA; Lacassagne MN; Lamure S; Letellier C; Menard AL; Daguindau E; Poiré X; Yakoub-Agha I; Guillaume T
    Bull Cancer; 2019 Jan; 106(1S):S35-S39. PubMed ID: 30580911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preservation/congelation of hematopoietic stem cell grafts in a pediatric context: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    De Vos J; de Berranger E; Jubert C; Pochon C; Letellier C; Mialou V; Sirvent A; Yakoub-Agha I; Dalle JH
    Bull Cancer; 2017 Dec; 104(12S):S136-S141. PubMed ID: 29169651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Loschi M; Alsuliman T; Cabrera Q; Desbrosses Y; Desmier D; Yakoub Agha I; Guillaume T
    Bull Cancer; 2024 Feb; 111(2S):S22-S28. PubMed ID: 36922321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC].
    Michel G; Detrait M; Elsermans V; Faucher C; Hicheri Y; Ivanova-Derin R; Lemarie C; Sirvent A; Top I; Garnier F; Boulanger F; Michallet M; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):147-8. PubMed ID: 24011969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
    Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
    J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Brissot E; Alsuliman T; Beauvais D; Bonnin A; Mear JB; Souchet L; Villate A; Yakoub-Agha I; Bazarbachi A
    Bull Cancer; 2020 Jan; 107(1S):S1-S6. PubMed ID: 31627903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study.
    Thibodeaux SR; Coble D; Day V; Fontaine MJ; Gabelli M; Gardiner N; Geach T; Schwartz J; Vasovic LV; Wyre R; Girdlestone J;
    Transfusion; 2023 Apr; 63(4):782-790. PubMed ID: 36924403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].
    Bay JO; Peffault de Latour R; Bruno B; Coiteux V; Guillaume T; Hicheri Y; Paillard C; Suarez F; Turlure P; Alain S; Bulabois CE; Socié G; Bauters F; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):152-4. PubMed ID: 24011961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC].
    Loiseau P; Dubois V; Bonafoux B; Bulabois CE; Coiteux V; Eliaou JF; Labaky M; Michallet M; Renac V; Delbos F; Kennel A; Detrait M; Devys A; Galambrun C; Yakoub-Agha I;
    Pathol Biol (Paris); 2014 Aug; 62(4):226-9. PubMed ID: 24973858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility].
    Cornillon J; Decanter C; Couturier MA; de Berranger E; François S; Hermet E; Maillard N; Marcais A; Tabrizi R; Vantyghem MC; Bauters F; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):164-7. PubMed ID: 24011968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatobiliary complications following allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
    Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
    Bull Cancer; 2020 Jan; 107(1S):S18-S27. PubMed ID: 30952358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis].
    Cornillon J; Vantyghem MC; Couturier MA; de Berranger E; François S; Hermete E; Maillard N; Marcais A; Tabrizi R; Decanter C; Duléry R; Bauters F; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):171-3. PubMed ID: 24011963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.